Literature DB >> 23934916

Animal models of gastrointestinal problems in Parkinson's disease.

James G Greene1.   

Abstract

Gastrointestinal (GI) symptoms are being increasingly recognized as early, common, and severe features of Parkinson's disease (PD), and they are important determinants of quality of life and disability throughout the disease course. In addition, the concept that GI symptoms could represent "pre-motor" PD has been hotly debated and has recently become a driving force for investigations into the pathophysiology and neuropathology of PD. Clinical data has been supported by many pathological studies demonstrating α-synuclein neuritic pathology and neuronal loss in central and peripheral areas relevant to GI function. As understanding has matured concerning the impact of GI dysmotility on patients and its potential relationship to incipient PD, behavioral and neuropathological examination of the GI tract has become a critical aspect of evaluation and validation of PD animal models. This review will briefly summarize GI symptoms and neuropathology in PD important to model in animals, behavioral and neuropathological examination of the GI tract in animals, and the current state of modeling parkinsonian GI dysfunction in animal model systems.

Entities:  

Mesh:

Year:  2011        PMID: 23934916     DOI: 10.3233/JPD-2011-11033

Source DB:  PubMed          Journal:  J Parkinsons Dis        ISSN: 1877-7171            Impact factor:   5.568


  5 in total

1.  Restoration of intestinal function in an MPTP model of Parkinson's Disease.

Authors:  L J Ellett; L W Hung; R Munckton; N A Sherratt; J Culvenor; A Grubman; J B Furness; A R White; D I Finkelstein; K J Barnham; V A Lawson
Journal:  Sci Rep       Date:  2016-07-29       Impact factor: 4.379

2.  The oral microbiome of early stage Parkinson's disease and its relationship with functional measures of motor and non-motor function.

Authors:  Dragos Mihaila; Jordan Donegan; Sarah Barns; Daria LaRocca; Qian Du; Danny Zheng; Michael Vidal; Christopher Neville; Richard Uhlig; Frank A Middleton
Journal:  PLoS One       Date:  2019-06-27       Impact factor: 3.240

3.  Gastrointestinal and metabolic function in the MPTP-treated macaque model of Parkinson's disease.

Authors:  Anna Delamarre; Cliona MacSweeney; Rie Suzuki; Alastair Jh Brown; Qin Li; Elsa Y Pioli; Erwan Bezard
Journal:  Heliyon       Date:  2020-12-23

Review 4.  Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice.

Authors:  Agata Aniszewska; Joakim Bergström; Martin Ingelsson; Sara Ekmark-Lewén
Journal:  Brain Behav       Date:  2022-06-01       Impact factor: 3.405

Review 5.  Neuroinflammation as a Factor of Neurodegenerative Disease: Thalidomide Analogs as Treatments.

Authors:  Yoo Jin Jung; David Tweedie; Michael T Scerba; Nigel H Greig
Journal:  Front Cell Dev Biol       Date:  2019-12-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.